Cite
HARVARD Citation
Hahn, S. et al. (n.d.). 402 Clinical performance comparison of RAS mutation detection in plasma and tissue samples from stage IV colorectal cancer patients for first-line anti-EGFR therapy selection. European journal of cancer. pp. S79-. [Online].